Acadia Healthcare (NASDAQ:ACHC) Trading Down 3.5% Following Analyst Downgrade

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) shares fell 3.5% on Thursday after Mizuho lowered their price target on the stock from $22.00 to $17.00. Mizuho currently has a neutral rating on the stock. Acadia Healthcare traded as low as $14.15 and last traded at $14.0210. 576,593 shares changed hands during mid-day trading, a decline of 77% from the average session volume of 2,463,338 shares. The stock had previously closed at $14.53.

Other equities analysts have also issued research reports about the stock. Barclays decreased their price target on shares of Acadia Healthcare from $17.00 to $14.00 and set an “equal weight” rating on the stock in a report on Thursday, December 4th. Weiss Ratings reiterated a “sell (d)” rating on shares of Acadia Healthcare in a research report on Wednesday, October 8th. Guggenheim lowered their target price on shares of Acadia Healthcare from $29.00 to $27.00 and set a “buy” rating on the stock in a research report on Monday, November 10th. Bank of America downgraded shares of Acadia Healthcare from a “neutral” rating to an “underperform” rating and dropped their price objective for the stock from $21.50 to $13.00 in a report on Wednesday, December 3rd. Finally, Leerink Partners reaffirmed a “market perform” rating and issued a $14.00 price target (down previously from $25.00) on shares of Acadia Healthcare in a research note on Wednesday, December 3rd. Eight equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $22.75.

Institutional Trading of Acadia Healthcare

A number of institutional investors and hedge funds have recently made changes to their positions in the company. Wellington Management Group LLP grew its holdings in Acadia Healthcare by 11.8% during the 3rd quarter. Wellington Management Group LLP now owns 9,423,548 shares of the company’s stock worth $233,327,000 after acquiring an additional 993,205 shares during the last quarter. Vanguard Group Inc. raised its holdings in shares of Acadia Healthcare by 7.8% in the third quarter. Vanguard Group Inc. now owns 9,417,045 shares of the company’s stock valued at $233,166,000 after purchasing an additional 681,278 shares during the last quarter. Abrams Bison Investments LLC increased its position in shares of Acadia Healthcare by 22.3% during the 3rd quarter. Abrams Bison Investments LLC now owns 4,380,000 shares of the company’s stock valued at $108,449,000 after purchasing an additional 800,000 shares during the last quarter. UBS Group AG raised its holdings in shares of Acadia Healthcare by 8.8% in the 3rd quarter. UBS Group AG now owns 4,336,698 shares of the company’s stock worth $107,377,000 after purchasing an additional 350,484 shares during the period. Finally, State Street Corp grew its stake in Acadia Healthcare by 3.2% in the 2nd quarter. State Street Corp now owns 3,095,775 shares of the company’s stock valued at $70,243,000 after buying an additional 95,670 shares in the last quarter.

Acadia Healthcare Price Performance

The company has a market capitalization of $1.29 billion, a P/E ratio of 11.98, a price-to-earnings-growth ratio of 3.45 and a beta of 0.91. The company has a quick ratio of 1.44, a current ratio of 1.44 and a debt-to-equity ratio of 0.73. The business’s 50-day moving average price is $18.81 and its 200 day moving average price is $21.21.

Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings results on Wednesday, November 5th. The company reported $0.72 EPS for the quarter, beating analysts’ consensus estimates of $0.71 by $0.01. Acadia Healthcare had a net margin of 3.29% and a return on equity of 7.66%. The company had revenue of $851.57 million during the quarter, compared to analyst estimates of $852.43 million. During the same period in the prior year, the business posted $0.91 EPS. The firm’s revenue was up 4.4% compared to the same quarter last year. Acadia Healthcare has set its FY 2025 guidance at 2.350-2.450 EPS. Analysts anticipate that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current fiscal year.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.